Glucotrack, Inc. (GCTK) shareholders
Close on Oct 19, 2026Market cap $3.43MP/E 0.0Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Drew Sycoff | 321,264 | 5.86% | 13G (passive) | Sep 5, 2024 |
| Armistice Capital, LLC Joint filing with Steven Boyd (9.99%) | 101,075 | 9.99% | 13G (passive) | Dec 31, 2025 |
| White Lion Capital LLC | 79,734 | 9.99% | 13G (passive) | Aug 26, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of GCTK | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Hrt Financial LP | 13,696 | 0.13% | $65.00K | +10,987 | 0.00% |
| Jane Street Group, LLC | 8,564 | 0.08% | $40.98K | New | 0.00% |
| Citadel Advisors LLC | 5,302 | 0.05% | $25.37K | New | 0.00% |
| Ikarian Capital, LLC | 3,055 | 0.03% | $14.62K | – | 0.00% |
| Geode Capital Management, LLC | 2,280 | 0.02% | $10.91K | −853 | 0.00% |
| Virtu Financial LLC | 1,248 | 0.01% | $6.00K | New | 0.00% |
| Granite Islands Private Wealth, LLC | 1,047 | 0.01% | $5.01K | New | 0.00% |
| Boothbay Fund Management, LLC | 902 | 0.01% | $4.31K | – | 0.00% |
| UBS Group AG | 889 | 0.01% | $4.26K | +842 | 0.00% |
| Citigroup Inc | 858 | 0.01% | $4.11K | New | 0.00% |
| Susquehanna International Group, Llp | 703 | 0.01% | $3.36K | New | 0.00% |
| Alerus Financial NA | 267 | 0.00% | $1.28K | – | 0.00% |
| Tower Research Capital LLC (TRC) | 229 | 0.00% | $1.10K | – | 0.00% |
| Barclays PLC | 84 | 0.00% | $402 | New | 0.00% |
| PlanVest Financial, Inc | 67 | 0.00% | $319 | New | 0.00% |
| Tradewinds Capital Management, LLC | 3 | 0.00% | $16 | New | 0.00% |
| Newbridge Financial Services Group, Inc. | 2 | 0.00% | $11 | – | 0.00% |
| SBI Securities Co., Ltd. | 1 | 0.00% | $3 | – | 0.00% |
| Osaic Holdings, Inc. | 0 | 0.00% | $0 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 19 | 0M | 0.4% | 9 / 2 | 1 / 3 | 0M | 0M |
| Q1 2026 | 13 | 0M | 0.1% | 4 / 2 | 0 / 1 | 0M | 0M |
| Q4 2025 | 10 | 0M | 0.0% | 2 / 2 | 3 / 0 | 0M | 0M |
| Q3 2025 | 8 | 0M | 0.0% | 1 / 2 | 2 / 3 | 0M | 0M |
| Q2 2025 | 10 | 0M | 0.0% | 10 / 0 | 0 / 0 | 0M | 0M |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Paul Goode | Chief Executive Officer, Director | 339 | 0.00% | Oct 7, 2025 |
| Peter C. Wulff | Chief Financial Officer | – | – | Feb 7, 2025 |
| Andrew K. Balo | Director | 4,692 | 0.04% | Oct 7, 2025 |
| Luis Malave | Director | 4,058 | 0.04% | Oct 7, 2025 |
| Brendel Victoria Carr | Director | – | – | Oct 7, 2025 |
| Erin Catherine Carter | Director | 2,148 | 0.02% | Oct 7, 2025 |
| John Ballantyne | Director, 10% owner | 2,747,717 | 25.97% | Mar 31, 2025 |
| Robert Fischell | Director | 2,045 | 0.02% | Mar 28, 2025 |
| Allen Danzig | Director | 1,922 | 0.02% | Mar 28, 2025 |
| A. Ballantyne Revocable Living Trust dated 08/01/2017 John | 10% owner | 2,743,591 | 25.93% | Mar 31, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Luis Malave Director | Oct 3, 2025 | Award | +463 | – | – | 4,058 |
| Andrew K. Balo Director | Oct 3, 2025 | Award | +1,285 | – | – | 4,692 |
| Erin Catherine Carter Director | Oct 3, 2025 | Award | +386 | – | – | 2,148 |
| Luis Malave Director | Jul 11, 2025 | Award | +1,200 | – | – | 3,595 |
| Andrew K. Balo Director | Jul 11, 2025 | Award | +3,332 | – | – | 3,407 |
| Erin Catherine Carter Director | Jul 11, 2025 | Award | +1,000 | – | – | 1,762 |
| John Ballantyne Director, 10% owner | Mar 26, 2025 | Award | +4,126 | – | – | 4,126 |
| Erin Catherine Carter Director | Mar 26, 2025 | Award | +1,896 | – | – | 45,632 |
| Luis Malave Director | Mar 26, 2025 | Award | +2,076 | – | – | 143,617 |
| Allen Danzig Director | Mar 26, 2025 | Award | +1,498 | – | – | 1,922 |
| Andrew K. Balo Director | Mar 26, 2025 | Award | +4,490 | – | – | 4,490 |
| Robert Fischell Director | Mar 26, 2025 | Award | +1,498 | – | – | 2,045 |
| Luis Malave Director | Mar 25, 2025 | Award | +35 | – | – | 2,395 |
| Andrew K. Balo Director | Mar 25, 2025 | Award | +75 | – | – | 75 |
| Erin Catherine Carter Director | Mar 25, 2025 | Award | +32 | – | – | 762 |
| Paul Goode Chief Executive Officer, Director | Mar 25, 2025 | Other | +42 | – | – | 339 |
| John Ballantyne Director, 10% owner | Mar 12, 2025 | Option exercise | +2,560,553 | – | – | 2,743,591 |
| Erin Catherine Carter Director | Mar 12, 2025 | Option exercise | +40,297 | – | – | 43,736 |
| A. Ballantyne Revocable Living Trust dated 08/01/2017 John 10% owner | Mar 12, 2025 | Option exercise | +2,560,553 | – | – | 2,743,591 |
| Luis Malave Director | Mar 12, 2025 | Option exercise | +133,532 | – | – | 141,541 |
| Paul Goode Chief Executive Officer, Director | Mar 12, 2025 | Option exercise | +15,435 | – | – | 18,989 |
| Paul Goode Chief Executive Officer, Director | Feb 5, 2025 | Other | +1,500 | – | – | 3,554 |
| John Ballantyne Director, 10% owner | Nov 14, 2024 | Other | +132,036 | $31.00 | $4.09M | 183,039 |
| Erin Catherine Carter Director | Nov 14, 2024 | Conversion | +2,078 | $31.20 | $64.83K | 3,439 |
| A. Ballantyne Revocable Living Trust dated 08/01/2017 John 10% owner | Nov 14, 2024 | Other | +132,036 | $31.00 | $4.09M | 183,039 |
| Luis Malave Director | Nov 14, 2024 | Conversion | +6,886 | $31.20 | $214.84K | 8,009 |
| Paul Goode Chief Executive Officer, Director | Nov 14, 2024 | Conversion | +796 | $31.20 | $24.84K | 2,054 |
| Drew Sycoff Director, 10% owner | Apr 22, 2024 | Buy | +182,539.6 | $1.26 | $230.00K | 2,951,258 |
| Erin Catherine Carter Director | Apr 8, 2024 | Award | +458 | – | – | 1,361 |
| Luis Malave Director | Apr 8, 2024 | Award | +489 | – | – | 1,123 |
| Allen Danzig Director | Apr 8, 2024 | Award | +229 | – | – | 424 |
| Robert Fischell Director | Apr 8, 2024 | Award | +229 | – | – | 547 |
| Erin Catherine Carter Director | Dec 31, 2023 | Award | +903 | – | – | 903 |
| Luis Malave Director | Dec 31, 2023 | Award | +362 | – | – | 634 |
| Luis Malave Director | Apr 20, 2023 | Award | +121 | – | – | 272 |
| Luis Malave Director | Jan 9, 2023 | Award | +29 | – | – | 151 |
| Luis Malave Director | Oct 4, 2022 | Award | +44 | – | – | 122 |
| Allen Danzig Director | Oct 4, 2022 | Award | +44 | – | – | 195 |
| Luis Malave Director | Jun 30, 2022 | Award | +34 | – | – | 78 |
| Luis Malave Director | Mar 31, 2022 | Award | +25 | – | – | 44 |
| Luis Malave Director | Dec 31, 2021 | Award | +11 | – | – | 19 |
| Luis Malave Director | Sep 30, 2021 | Award | +8 | – | – | 8 |
| Robert Fischell Director | Aug 24, 2021 | Award | +318 | – | – | 318 |
| Angela Strand Boydston Director | Mar 20, 2017 | Award | +13,334 | – | – | 13,334 |
| Angela Strand Boydston Director | Mar 20, 2017 | Award | +4,445 | – | – | 4,445 |
| Leslie Seff Director | Mar 20, 2017 | Award | +3,334 | – | – | 3,334 |
| Zvi Cohen Director | Mar 11, 2015 | Other | −120,077 | – | – | 241,625 |
| David Malka Vice President of Operations, Director | Mar 11, 2015 | Other | −61,471 | – | – | 123,695 |
| Avner Gal Chairman and CEO, Director | Mar 11, 2015 | Other | −136,162 | – | – | 273,989 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Glucotrack's stock actually held short. Settlement fails (shares not delivered on time) peaked at 1,735,514 shares on Sep 25, 2026 over the last 90 days.
See a number that looks wrong?